variednews: GemVax's highly promising Phase II Alzheimer's dis...

variednews: GemVax's highly promising Phase II Alzheimer's dis...: SEOUL, South Korea, March 30: GemVax & KAEL Co., Ltd. (Korea: 082270) ("GemVax") has announced that a paper on GV1001, a ...

Comments

Popular posts from this blog

Arthur Lawrence Expands Its Footprint To The UAE

XREX Raises $17M to Expand Fiat Currency Portfolio and Partnerships

Blue Health Intelligence Hires Chief Strategy and Growth Officer